DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2169.2547.95 (+2.26 %)
PREV CLOSE ( ) 2121.30
OPEN PRICE ( ) 2125.00
BID PRICE (QTY) 2169.25 (25)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25863
TODAY'S LOW / HIGH ( )2125.00 2183.65
52 WK LOW / HIGH ( )1901.65 2948
NSE2167.0543.6 (+2.05 %)
PREV CLOSE( ) 2123.45
OPEN PRICE ( ) 2142.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2167.05 (393)
VOLUME 743506
TODAY'S LOW / HIGH( ) 2135.05 2185.00
52 WK LOW / HIGH ( )1901.15 2948.8
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
16Feb Dr. Reddy’s Laboratories trades in gre
Dr. Reddy’s Laboratories is currently trading at Rs. 2219.60, up by 25.1..
09Feb Lupin, Dr. Reddy’s and Satin Creditcar
Lupin has launched Clonidine Hydrochloride extended-release tablets, 0.1..
09Feb Dr. Reddy’s recalls over 80,000 bottle
Dr. Reddy’s Laboratories has initiated voluntary recall of over 80,000 b..
09Feb Dr. Reddy’s slips on recalling Atorvas
Dr. Reddy’s Laboratories is currently trading at Rs. 2142.00, down by 36..
02Feb Dr. Reddy’s launches Tetrabenazine Tab
Dr. Reddy’s Laboratories has launched Tetrabenazine Tablets, a therapeut..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit296913841
Gross Profit 3716 15445
Operating Profit 583223368
Net Sales 2523097198
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Merck (BSE)
 1486.60 (2.96%)
M.Cap (Rs. in Cr)2467.66
Abbott India (BSE)
 5788.40 (0.72%)
M.Cap (Rs. in Cr)12299.95
Zandu Realty (BSE)
 1993.80 (1.95%)
M.Cap (Rs. in Cr)160.78
Piramal Enterprises (BSE)
 2622.05 (1.31%)
M.Cap (Rs. in Cr)47275.73
Divis Lab (BSE)
 1049.55 (3.07%)
M.Cap (Rs. in Cr)27862.25
Shareholding Pattern
PROMOTERS 26.76%
NON-INSTITUTION 15.19%
MUTUAL FUNDS/UTI 9.33%
FI/BANKS/INSURANCE 5.96%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.